Iteris, Inc. Stock News

ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. (ITI), a clinical-stage biotechnology company focused on developing transformative immune therapies through its proprietary UNITE® platform, announced today that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has cleared the Clinical Trial Notification (CTN) for ITI-9001, the Company's investigational immunotherapy fo...

Key certification milestone underscores capability for seamless and secure communication with connected vehicles and infrastructure components Key certification milestone underscores capability for seamless and secure communication with connected vehicles and infrastructure components

AUSTIN, Texas, May 19, 2026 (GLOBE NEWSWIRE) -- Iteris, Inc., the world's trusted technology ecosystem for smart mobility infrastructure management and part of the Almaviva Group, today announced the launch of Iteris VantageNode™, a compact, AI-powered intersection detection solution designed to deliver high-performance vehicle, pedestrian, and bicycle detection at small, underserved, and less ...

FDOT District 7 has chosen Iteris to provide comprehensive operations and management support for the District's Regional Transportation Management Center.